Timothy D. Murtha, MD, MHS is a surgeon at Brown Surgical Associates specializing in the field of surgical oncology in both the research laboratory and the clinical setting. He is interested in improving the diagnosis and treatment of malignancies of the pancreas, liver, and biliary system. He is currently exploring the role of circulating exosomes in detecting pancreatic cancer in high-risk populations.
Dr. Murtha earned his medical degree from Tufts University School of Medicine. He then joined the surgical residency program at Yale School of Medicine where he completed a post-doctoral research fellowship at the Yale Endocrine Neoplasia Laboratory and obtained a Masters of Health Science studying the genetic drivers of Adrenocortical Carcinoma. Dr. Murtha went on to round out his training through the Complex General Surgical Oncology Fellowship program at Memorial Sloan Kettering Cancer Center.
Specialties
Board Certification:
American Board of Surgery
Education:
Tufts University School of Medicine - Boston, MA
Residency:
Yale School of Medicine - New Haven, CT
Fellowship:
Post-Doctorar Research Fellowship - Yale Endocrine Neoplasia Laboratory, New Haven, CT
Complex General Surgical Oncology Fellowship - Memorial Sloan Kettering Cancer Center, New York, NY
Memberships in Societies:
American College of Surgeons
New England Surgical Society
Society of Surgical Oncology
Hospital Affiliations:
Rhode Island Hospital
The Miriam Hospital
Women and Infants Hospital
In the News
- Surgeon, Researcher Timothy Murtha, MD Joining Brown Surgical Associates’ Division of Surgical Oncology (11/1/2022)
Publications
1. Moore MS, Reichard JD, Murtha TD, Zahedi B, Fallier RM, Kunz TH. Specific alterations in complement protein activity of little brown myotis (Myotis lucifugus) hibernating in white-nose syndrome affected sites. PLoS One. 2011 Nov
2. Moore MS, Reichard JD, Murtha TD, Nabhan ML, Pian RE, Ferreira JS, et al. Hibernating little brown myotis (Myotis lucifugus) show variable immunological responses to white-nose syndrome. PLOS one. 2013 Mar
3. Murtha TD, Carling T, Scholl UI. Pregnancy, Primary Aldosteronism, and Somatic CTNNBI Mutations. N Engl J Med. 2016 Apr
4. Murtha TD, Korah R, Carling T. Suppression of cytochrome P450 4Bl : An early event in adrenocortical tumorigenesis. Surgery. 2017 Jan
5. Cheng J Y, Brown TC, Murtha TD, et al. A novel FOXOI -mediated dediffel•entiation blocking role for DKK3 in adrenocortical carcinogenesis. BMC Cancer, 2017 Mar
6. Murtha TD, Blown TC, Rubinstein JC, Haglund F, Juhtin CC, Larsson C, Korah R, Carling T. Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma. Surgery. 2017 Jun
Stenman AS, Murtha TDS Carling T. Suppression of Forkhead Box Protein 01 (FOXOI)
Transcription Factor May Pzomote Adrenocortical Tumorigenesis. Horm Metab Res. 2017 Aug
8. Murtha TD, Lupsa BC, Majumdar S, Jain D, Salem RR. A Systematic Review of ProinsulinSecreting Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. 2017 Aug
9. Murtha TD, Han G, Han D. Pledictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients who have Nodal Staging. Ann Surg Oncol. 2018 Apr
10. Nicolson NG, Murtha TD, Dong W, Paulsson JO, Choi J, Barbieri AL, Brown TC, Kunstman JW, Larsson C, Prasad ML, Korah R, Lifton RP, Juhlin CC, Carling T. Comprehensive Genetic
Analysis of Follicular ThY10id Carcinoma Predicts Prognosis Independent of Histology. J Clin Endocrinol Metal). 2018 May
l l. Blown TC, Murtha TD, Rubinstein JC, Korah R, Carling T. SLC12A7 alters adrenocortical carcinoma cell adhesion propetties to promote an aggressive invasive behavior. Cell Conunun Signal. 2018 Jun
12. Sasanatcietkul T, Murtha TD, Javid M, Korah R, Carling T. Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer. Mol Cell Endocrinol. 2018 July
13. Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, carling T, Biickdahl M, Wang N, Juhlin CC, Larsson C. Altered TERT promoter hypermethylation is associated with poor prognosis in cancer. Int J ofMol Med 2018 Sept
14. Murtha TD, Hun D. ASO Author Reflection: Predictors for Use of Sentinel Node Biopsy and the
Association with Improved Survival in Melanoma Patients who have Nodal Staging. Ann Surg Oncol. 2018 Oct
15. Riccardi A, Aspir T, Shen L, Kuo CL, Brown TC, Korah R, Murtha TD, Bellizzi J, Parham K, Carling T, Costa-Guda J, Amold A. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas. J Clin Endocrinol Metab. 2019 Jun
16. Murtha TD, Ahuja N. Hey Siri, Should 1 Get a Medical Degree? The ASCO Post. 2019 sept
17. Murtha TD, Kunsnnan JW, Healy JM, Yoo PS, Salem RR. A Critical Appraisal of the July
Effect: Evaluating Complications Following Pancreaticoduodenectomy. J Gastrointestinal Surg. 2019 Aug
18. Murtha TD, Cornman-Homonoff J, Ayyagari R, Zhang X, Salem RR. A Novel Treatment for Metastatic Serous Cystadenocarcinoma Using a Microwave Ablation: Case Report and Review of the Literature. Pancreas. 2021 Mar
19. Vincze S, Peters N, Kuo C, Brown TC, Korah R, Murtha TD, Bellizzi J, Riccardi A, Parham K, Carling T, Costa-Guda J, and Arnold A. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism. J Clin Endocrinol Metab. Submitted Sept 2021. (Under review)
